Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
Medolin 2 mg tablets.
| Pharmaceutical Form |
|---|
|
Tablet. Pink, round, flat, scored, tablets with diameter 7 mm. |
Each tablet contains Salbutamol sulphate equivalent to salbutamol 2 mg.
Excipient with known effect: lactose monohydrate. Each tablet contains 118.1 mg lactose monohydrate.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Salbutamol |
Salbutamol is a selective β2-agonist providing short-acting (4-6 hour) bronchodilation with a fast onset (within 5 minutes) in reversible airways obstruction. At therapeutic doses it acts on the β2-adrenoceptors of bronchial muscle. Salbutamol is administered for the symptomatic relief of bronchospasm associated with chronic or acute asthma, bronchitis or other obstructive pulmonary diseases. |
| List of Excipients |
|---|
|
The excipients are: Lactose monohydrate |
Primary packaging: PVC – Aluminium foil blisters.
Secondary packaging: Cast coated Carton boxes with information leaflet.
Pack sizes available: Boxes of 50, 100, 1000 tablets in blisters.
Not all pack sizes may be marketed.
MEDOCHEMIE LTD, 1-10 Constantinoupoleos street, 3011 Limassol, Cyprus
19931
20/12/2005 (date of authorisation)
| Drug | Countries | |
|---|---|---|
| MEDOLIN | Cyprus, Hong Kong |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
